H1B Salary Data

Home › Employers › Bio-Synthesis, Inc.

Bio-Synthesis, Inc.: H-1B salaries and sponsorship

Bio-Synthesis, Inc. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $75,000.

Applications (LCAs)4
Certified4
Employer addressLewisville, TX
H-1B dependent employerNo
Median offered salary$75,000
Middle half of salaries$72,000–$78,000
10th–90th percentile$72,000–$78,000

Does Bio-Synthesis, Inc. sponsor H-1B visas?

Bio-Synthesis, Inc. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 1, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Laboratory Research Associate4$75,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$78,000
FY20241$72,000
FY20251$78,000
FY20261$72,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Laboratory Research Associate$72,000
Level II
Lewisville, TXApr 1, 2026Oct 1, 2026Certified
Laboratory Research Associate$78,000
Level I
Lewisville, TXApr 2, 2025Oct 1, 2025Certified
Laboratory Research Associate$72,000
Level II
Lewisville, TXOct 6, 2023Oct 7, 2023Certified
Laboratory Research Associate$78,000
Level II
Lewisville, TXApr 13, 2023Oct 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).